Viemed Healthcare Inc. (VMD) exhibits 57.5% gross margins and 13.0% return on invested capital within Health Care (Misc Health and Biotechnology Services), balanced against a 6.6x enterprise multiple and 4.8% implied options volatility.
Sustained 57.5% gross profitability converts into 8.5% operating margin and 13.0% ROIC, outpacing sector cost of capital.
ROIC: 13.0% // GM: 57.5%YoY revenue trajectory of +20.5% paired with 3.15% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +20.5% // FCF YLD: 3.15%Altman Z-Score of 6.59 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 6.59 // F-SCORE: 9/9Trading at 24.6x trailing P/E (20.7x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.6x // EV/EBITDA: 6.6xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $9.95 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Misc Health and Biotechnology Services require continuous execution to defend 5.7% net margins.
NET MARGIN: 5.7% // D/E: 0.08x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for VMD & activate live FRED threshold breach alerts.